top of page

Our Company

Overview

IVT Medical Ltd. is a pioneering Research & Development company dedicated to advancing medical device technology in the field of wound healing and closure. With a strong commitment to innovation, we focus on developing affordable, safe, and effective state-of-the-art technologies. In addition to product development, we offer expert consulting and educational services to help healthcare providers integrate advanced wound management solutions. Through these efforts, we aim to enhance global healthcare outcomes and contribute to the continuous improvement of patient care.
 

Technological Innovations

  1. TopClosure® Tension Relief System (TRS)
    The TopClosure® Tension Relief System (TRS) technology leverages stress relaxation and mechanical creep to effectively harness the skin's viscoelastic properties, ensuring optimal tension management and facilitating enhanced wound closure.

  2. Regulated Oxygen-Enriched and Irrigation-Negative Pressure-Assisted Wound Treatment (ROINPT)
    The ROINPT technology integrates oxygen to combat anaerobic infections while simultaneously providing hydrodynamic wound cleansing, enhancing the healing process.

  3. Controlled In-Situ Targeted Ultra-High Concentration Antibiotic Administration (CITA)
    The CITA methodology revolutionizes antimicrobial delivery, effectively combating localized infections and managing resistant wounds by directly delivering antibiotics at ultra-high concentrations.

     

Device Innovations

  1. TopClosure® Tension Relief System (TRS)
    Our flagship product, the TopClosure® Tension Relief System (TRS), is expertly designed to manage complex wounds in various settings, including civil, military, and mass-casualty situations. The TRS is widely used across specialties such as surgery, orthopedics, cardiothoracic, vascular surgery, and trauma care. By redistributing stress away from the wound edges, the system significantly reduces tension, facilitating the closure of high-tension, difficult-to-heal wounds, and often eliminating the need for skin grafts or flaps. This approach reduces surgical complexity and improves scar aesthetics.

  2. Vcare α®
    The Vcare α® is a novel, non-pharmaceutical wound healing device. Drawing on original scientific principles and extensive clinical experience, it utilizes Regulated Oxygen-Enriched and Irrigation-Negative Pressure-Assisted Wound Treatment (ROINPT) to combat anaerobic infections through the strategic application of oxygen. The Vcare α® integrates advanced software, electronics, and alarm systems to minimize bleeding risks and enhance safety, all while being tailored to meet the specific clinical needs of patients.

Recent Expansions:

MeCare α®
We have recently expanded our product portfolio with the introduction of MeCare α®, a portable ROINPT-compatible device designed for both hospital and home use. This addition enhances patient mobility and extends our reach into home care wound therapy, including applications in rural and low-resource settings.

 

CITA Methodology
Spearheaded by Moris Topaz, MD, PhD, our CEO, the Controlled In-Situ Targeted Ultra-High-Concentration Antibiotics Administration (CITA) methodology has revolutionized the treatment of localized resistant infections. Evolving from over 15 years of rigorous basic science and clinical research, CITA enables the direct delivery of antibiotics to the infection site at ultra-high concentrations. By maintaining these elevated antibiotic levels, CITA aims to overcome resistance mechanisms and maximize treatment efficacy.

CITA Antibiotic Strategy
The in-situ component of CITA allows for the direct administration of antibiotics at the infection site via local instillations or catheter-based delivery. This innovation minimizes systemic antibiotic exposure, which has been shown to be safe and may reduce systemic risks and side effects. CITA is particularly effective in combating resistant infections, including biofilms and high bacterial loads, which conventional antibiotic methods cannot adequately address.

 

Integrated Approach

When used together, the TopClosure®, Vcare α®, and CITA technologies introduce a groundbreaking approach to wound management. This integrated system has the potential to redefine early wound closure across a spectrum of surgical applications, establishing new standards of care.
 

Conclusion

With a relentless commitment to research, clinical evaluation, and technological innovation, IVT Medical Ltd. is at the forefront of developing solutions with significant global implications. Our innovations aim to optimize antibiotic administration, reduce resistance formation, improve wound healing, enable early closure, and enhance patient functionality.

Read Scientific Publications Featuring Our Work

Simple Solutions For Complex Problems

Products

TopClosure®

Leg_Master__edited.png

TopClosure® System may serve as an essential device for dynamic acute & chronic wound closure and secure in a broad range of applications. By its wide distribution of stress to the skin away from the wound edges, tension on the scar can be substantially reduced, thus enabling closure of extremely hard to close wounds and improving the quality and aesthetics of scar.

Vcare α®

vcare_upscayl_2x_realesrgan-x4plus-anime_edited.png

The Vcare α® was designed to provide a pre-set regulated negative pressure to open wounds with the intent to minimize the risk of bleeding, focusing on patient's specific clinical needs. We put emphasis on research and clinical assessment while improving this technology to maximize its safety, functional efficacy and quality performance. The Vcare α® is equipped with specially designed user friendly software & electronics for bleeding detection and alarms control (complies with IEC-60601-1-8 standards)for better detection and control of bleeding.

Mecare α®

20220606_122323-removebg-preview (1)_upscayl_5x_realesrgan-x4plus-anime_edited.png

The MeCare α®  is designed to provide a pre-set regulated negative pressure to open, small to medium size wounds for home and hospital applications.
The MeCare α®  may promote wound healing by either growth of granulation tissue, by removal of excess exudates or irrigation fluids and infectious materials. It is intended for management of chronic, acute, traumatic, sub-acute and dehisced, small to medium size wounds, small partial-thickness burns, ulcers (i.e., diabetic or pressure), flaps and grafts. 
Regulated, vacuum-assisted treatment by MeCare α® can be improved by combining with the administration of low flow oxygen and irrigation to the wound (regulated oxygen-enriched and irrigation negative pressure treatment; ROI-NPT), for prevention and reduction of anaerobic infection, and for accelerated evacuation of bacteria, in order to enhance wound healing.

"Big results require big ambitions"

Heraclitus

Get in Touch

16 Hatidhar St.
POB: 2340
Ra'anana 4366518
ISRAEL

972-9-7463737

Thanks for submitting!

©2021 by ivtmedical. 

bottom of page